TickerFactsScreenerDevelopers

Akari Therapeutics Plc (AKTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2004: $02005: $1.23M2006: -$467.0K2007: -$60.0K2008: -$1.26M2009: -$1.70M2010: -$2.00M2011: -$2.48M2012: -$3.36M2013: $400.7K2014: $2.22M2015: $48.72M2016: $34.10M2017: $22.24M2018: $4.37M2019: $7.6K2020: $9.38M2021: $5.55M2022: $1.79M2023: -$229.0K2024: $22.23M2025: $28.33M$28.33M
2004Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$28.33M+27.4%
2024$22.23M+9807.0%
2023-$229.0K-112.8%
2022$1.79M-67.8%
2021$5.55M-40.8%
2020$9.38M+123410.4%
2019$7.6K-99.8%
2018$4.37M-80.4%
2017$22.24M-34.8%
2016$34.10M-30.0%
2015$48.72M+2091.3%
2014$2.22M+454.9%
2013$400.7K+111.9%
2012-$3.36M-35.2%
2011-$2.48M-24.0%
2010-$2.00M-17.8%
2009-$1.70M-35.2%
2008-$1.26M-1996.7%
2007-$60.0K+87.2%
2006-$467.0K-137.9%
2005$1.23M—
2004$0—